Chemicals Used in Paint Strippers, Vapor Degreasing May Be Banned; EPA to Evaluate Chemicals Grandfathered in Under Old TSCA

| April 13, 2017

article image
A slew of chemical regulations that will affect manufacturers and other industrial sectors have been proposed this week by the EPA. Three toxic chemicals, two used in paint strippers and one in vapor degreasing, will likely be banned following EPA notices published this week.

Spotlight

Inovio Pharmaceuticals Inc.

Inovio is revolutionizing the fight against cancer and infectious diseases. Our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include Roche, MedImmune.

OTHER ARTICLES

CHEMICAL SPILL PREVENTION

Article | February 28, 2020

When it comes to your workplace, nothing should be prioritized over the safety of your employees. As your greatest asset to your business, they should feel safe in their work environment. Maintaining a safe work environment is a particularly important consideration for companies who work with or store hazardous materials. And it is not only critical for the appeasement of the Occupational Health and Safety Administration (OSHA) and the Environmental Protection Agency (EPA) requirements but the well-being and safety of your employees. That’s why, in this article, we will discuss chemical spill prevention in your workplace facility.

Read More

We need a global agreement that sets targets for reducing plastic waste

Article | May 20, 2021

What follows is an entirely personal take on the challenge of plastic waste and does not represent the views of ICIS or any other expert opinion I have sought out. The views are put forward in the spirit of debate as we move forward, as an industry, to solve the crisis of plastic waste.

Read More

Improving Pump Seal Reliability for Bay Area Petrochem Plants

Article | March 10, 2020

Keeping thousands of pumps in San Francisco Bay Area refineries running 24/7/365 requires a well-planned and well-executed maintenance strategy. Unplanned failures may have ramifications for safety, budget, and compliance—especially with regard to Bay Area Air Quality Management District (BAAQMD) regulations. One of the most mission-critical elements for smooth operations is pump seal reliability. Many plants run pumps outside the safe operating envelope and replace them only when economically feasible. Over time, however, you increasingly risk catastrophic downtime. Fortunately, you have the means to largely mitigate pump seal reliability problems with awareness and proactive management of conditions to improve safety and compliance.

Read More

The supply-chain inflation threat to petrochemicals demand

Article | May 9, 2021

Petrochemicals themselves remain in short supply. This is partly because of reduced feedstock from refineries, a consequence of the pandemic-related collapse in transportation fuels demand.Global petrochemical supply is still edging back to something like normal following the US winter storms in February, during which most US capacity was shut down. A point of discussion is whether containers will become available in the right places at the right prices to relieve tightness in the European polyethylene (PE) market, once US supply has normalised. The container issue is making it difficult to move PE and polypropylene (PP) cargoes from Asia to Europe.Market intelligence from the US-based ICIS CDI team indicates that enough container freight space will be available to resume significant shipments of US PE to Europe, albeit at high prices. It will be several more weeks before domestic pipelines have been refilled, enabling US producers to refocus on exports, added CDI.

Read More

Spotlight

Inovio Pharmaceuticals Inc.

Inovio is revolutionizing the fight against cancer and infectious diseases. Our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include Roche, MedImmune.

Events